ACTEMRA
HOFFMANN-LA ROCHE LIMITED
Quick answers
Is there a shortage of ACTEMRA in Canada?
No. There is no current shortage of ACTEMRA 162MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Avtozma, Actemra & Tyenne (Tocilizumab) Shortage in Canada
Whether tocilizumab — Actemra and its biosimilars Avtozma and Tyenne — is in shortage in Canada right now, what anticipated and avoided shortage reports mean, and what to ask before switching brands.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
ACTEMRA
HOFFMANN-LA ROCHE LIMITED
AVTOZMA
CELLTRION INC.
DIN
02483327
Strength
162MG
Dosage Form
SOLUTION
Route
SUBCUTANEOUS
Compare with another product →
Shortage History
Other Products from HOFFMANN-LA ROCHE LIMITED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
400MG · DIN 02350114
200MG · DIN 02350106
162MG · DIN 02424770
80MG · DIN 02350092
DIN 02225689
DIN 02147440
150MG · DIN 02458136
25MG · DIN 02270994
2MG · DIN 02245859
200MG · DIN 02242145
250MG · DIN 02192748
500MG · DIN 02237484